Category.Links
- Organizations
- Newly.Diagnosed
- Staging, Guidelines, Educational.Material, Photos
- Treatment.Options
- Articles
- Patient.Perspectives
- Lymphatic.System, Pathology, Anatomy, Medical.Terminology
- Wound.Care, Cancer.Care, Survivorship
- Psychology.Of.Cancer, Cancer.Myths
- Recurrent.Melanoma
- Multiple.Primaries, Unknown.Primaries, Atypical.Nevi, Mole.Mapping
- Radiology
- Sunscreen, Clothing, Melanoma.Items
- Pregnancy
- Insurance, SSDI, SSI
- Sideline.Issues
articles
Melanoma is currently the subject of ongoing research. New articles are being published frequently but they need to be considered carefully. Variables like sample size, publication date, and whether there are opposing view must be taken into account. Today's miracle for a lucky few might be tomorrow's failure when applied to a larger population. Conversely, today's failure might be tomorrow's miracle with a few small adjustments. Being an education patient is important, but remember this is called research.
melanoma
Melanoma - A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites.
There are 46 links on this page, so please scroll down.
general.articles
- Clinical Diagnosis of Early Malignant Melanoma: Expansion of the ABCD Criteria to Improve Diagnostic Sensitivity
- Current Melanoma articles from the PLOS
- Doctor's Balk at cancer ad, citing lack of evidence
- Melanoma and Other Skin Cancers In-Depth
- Mitotic Rate in Melanoma: A Reexamination
- Mohs Micrographic Surgery
- Melanoma: 2008 ASCO Annual Meeting
- Prognostic value of S100B levels and LDH levels in melanoma patients.
risk for.other cancers
- BRCA Mutations and Other Cancer Risks
- Endometriosis increases melanoma risk
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds with p16 (ink4) Mutations
- Melanoma Cancer Risk Evaluation Program
- New Research Into Melanoma Risk
- Risk Factors for Melanoma
- Study: Breast Cancer tied to Malignant Melanoma risk
- The association between melanoma, lymphoma, and other primary neoplasms
Vitamin.D
Blood and Tissue.Donation
- American Red Cross - Blood Donor Eligibility Guide
- California Blood Bank Society - Donor Deferral
- Medical Guidelines for Joining the National Marrow Donor Program
pediatric.melanoma
- Melanoma on the rise among children
- National Cancer Institute - Rare Childhood Cancers
- Pediatric and Adolescent Melanoma: Review of Therapies and Access to Clinical Trials
- Pediatric Melanoma Rates Continue to Rise
- St. Jude's Children's Research Hospital - Melanoma
stage.one
- Editorial: Should Tumor Mitotic Rate and Patient Age, As Well As Tumor Thickness, be Used to Select Melanoma Patients for Sentinel Node Biopsy?
- Melanoma Treatment Stage I - National Cancer Institute
- Prognostic Factors of Thin Cutaneous Melanoma: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society
- Stage I Melanoma - CancerConsultants.com
- Thin Primary Cutaneous Malignant Melanoma: A Prognostic Tree for 10-Year Metastasis Is More Accurate Than American Joint Committee on Cancer Staging
stage.two
- Melanoma Treatment Stage II - National Cancer Institute
- Prognostic Implications of Thick (>=4-mm) Melanoma in the Era of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy
- Stage II Melanoma - CancerConsultants.com
- The Prognosis of Patients With Thick Primary Melanomas: Is Regional Lymph Node Status Relevant, and Does Removing Positive Regional Nodes Influence Outcome?
- Vascular Involvement in the Prognosis of Primary Cutaneous Melanoma, Arch Dermatol, September 2001
stage.three
- Melanoma - Stage III News
- Winning Her Battle Against Stage III Melanoma (SkinCancerNet Article)
- Calculation of Survival of Patients With Stage III Melanoma
- Serial Monitoring of Circulating Melanoma Cells During Neoadjuvant Biochemotherapy for Stage III Melanoma: Outcome Prediction in a Multicenter Trial
- Estimating Survival Probability in Stage III Melanoma: A Multivariable Individualized Patient Risk Assessment Nomogram
- Survival in patients with synchronous versus metachronous lymph node (LN) involvement in stage III melanoma: Is there a difference?
stage.four
- Gene Therapy Beats Back Skin Cancer
- Stage IV - CRP is superior to LDH
- Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy
- Staging and prognostic factors for stage IV melanoma: Initial results of an AJCC international evidence-based assessment of 4,895 melanoma patients.